Chimeric allergen receptor regulatory T cells suppress birch pollen allergic airway inflammation
Journal of Experimental Medicine · 2026
DOI: 10.1084/jem.20252201 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Experimental Medicine, 2026. Verfasst von Ana Alcaraz-Serna und 18 weiteren Autor:innen. Beteiligte Einrichtung: Division of Immunology and Allergy, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland. Hauptthemen laut MEDLINE: T-Lymphocytes, Regulatory, Betula, Pollen, Allergens. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Gabriella Giorgi-Cavaglieri Foundation, Martin Escudero Foundation, Machaon Foundation.
Abstract (Originalsprache)
Asthma is a deadly chronic respiratory disease affecting over 300 million people. While allergen immunotherapy remains the only disease-modifying treatment, it is poorly applicable for patients with severe asthma. Here, we explored the therapeutic potential of regulatory T cells (Tregs) armed with chimeric allergen receptors—named CAlleR—redirected against the major allergen of birch pollen Bet v1. Four novel anti-Bet v1 antibodies were identified and used to engineer and functionally validate CAlleR. CAlleR Tregs showed specific in vitro activation and suppression and significantly reduced the airway hyperresponsiveness in birch pollen–sensitized mice. Mechanistically, CAlleR Tregs migrated to the lungs and mediastinal lymph nodes, interacted with CD11c+ dendritic cells, and were activated in a FcγR-dependent manner by cross-presenting Bet v1 stabilized with noncompetitive anti-Bet v1 antibodies. These findings unveil a novel mechanism for targeting soluble antigens and highlight the potential of CAlleR Tregs to prevent and treat severe allergies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Division of Immunology and Allergy, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.
- Division of Pulmonary Medicine, Department of Medicine, Lausanne University Hospital (CHUV), University of Lausanne, Lausanne, Switzerland.
- Center of Human Immunology Lausanne , Lausanne, Switzerland.
ORCID-Profile: Ana Alcaraz-Serna, Noémie Chillier, Aurélien Trompette, Laura Ermellino, Raphaël Porret, Erica Lana, Rebecca Cecchin, Apiha Shanmuganathan, Seher Guney, Oscar Alfageme-Abello, Eleonora Pace, Antonio Mancarella, Jeremy Campos, Mathilde Foglierini, Christophe von Garnier, Craig Fenwick, Laurent Perez, Niki Ubags, Yannick D Muller
Förderung
- Gabriella Giorgi-Cavaglieri Foundation
- Martin Escudero Foundation
- Machaon Foundation
Zitieren
APA
Alcaraz-Serna, A., Chillier, N., Trompette, A., Ermellino, L., Porret, R., Lana, E., Cecchin, R., Shanmuganathan, A., Guney, S., Alfageme-Abello, O., Pace, E., Mancarella, A., Campos, J., Foglierini, M., von Garnier, C., Fenwick, C., Perez, L., Ubags, N., & Muller, Y. D. (2026). Chimeric allergen receptor regulatory T cells suppress birch pollen allergic airway inflammation. Journal of Experimental Medicine. https://doi.org/10.1084/jem.20252201
Vancouver
Alcaraz-Serna A, Chillier N, Trompette A, Ermellino L, Porret R, Lana E, et al. Chimeric allergen receptor regulatory T cells suppress birch pollen allergic airway inflammation. Journal of Experimental Medicine. 2026. doi:10.1084/jem.20252201
BibTeX
@article{AlcarazSerna2026,
author = {Alcaraz-Serna, Ana and Chillier, Noémie and Trompette, Aurélien and Ermellino, Laura and Porret, Raphaël and Lana, Erica and Cecchin, Rebecca and Shanmuganathan, Apiha and Guney, Seher and Alfageme-Abello, Oscar and Pace, Eleonora and Mancarella, Antonio and Campos, Jeremy and Foglierini, Mathilde and von Garnier, Christophe and Fenwick, Craig and Perez, Laurent and Ubags, Niki and Muller, Yannick D},
title = {Chimeric allergen receptor regulatory T cells suppress birch pollen allergic airway inflammation},
journal = {Journal of Experimental Medicine},
year = {2026},
doi = {10.1084/jem.20252201}
}
EUVIMED